Should we fear the rise in Covid cases: Why people are wearing masks again!

Follow summer safety tips, especially for vulnerable groups. Covid-19 infections are indeed on the rise, and there’s a lot to unpack about what’s happening right now. New Covid-19 vaccines targeting variants are expected soon. Stay cautious and updated to protect against the rise in infections.
Should we fear the rise in Covid cases: Why people are wearing masks again!

As the summer sun shines brightly, so too does the surge in Covid-19 cases across the United States. If it seems like more people around are getting sick, you’re not alone. Covid-19 infections are indeed on the rise, and there’s a lot to unpack about what’s happening right now.
According to the Centers for Disease Control and Prevention (CDC), Covid-19 infections are increasing in 39 states, with no signs of decline anywhere in the country.
This suggests that a summer wave of infections is currently underway.
The CDC has stopped tracking individual Covid-19 cases, but it estimates transmission levels based on emergency department visits. Both Covid-19-related deaths and emergency visits have risen in the past week, and hospitalizations have climbed by 25% from late May to early June. In California, there is a noticeable rise in infections, with Covid-19 levels in wastewater increasing and a jump in the positivity rate from 3% to 7.5% over the last month.
Dr. Thomas Russo, chief of infectious diseases at the University at Buffalo, told NBC news notes that this uptick in cases suggests the beginning of a summer wave. Covid-19 infections spike in the summer due to increased travel and indoor gatherings, driven by the need to escape the heat.

FLiRT covid variant update: America under fear, does India be worried too?


New variants emerging

Adding to the complexity are several new variants contributing to the nationwide increase in Covid-19 cases. Dr. Dan Barouch, director of the Center for Virology and Vaccine Research in Boston, highlights the rise of three new variants: KP.2, KP.3, and LB.1. These variants are all descendants of JN.1, the strain that dominated this past winter.

KP.2 became the dominant variant in the U.S. last month, followed by KP.3 in early June. Together with KP.1.1, these variants are collectively responsible for about 63% of current Covid-19 infections in the U.S. Some scientists refer to these variants as “FLiRT,” due to their amino acid changes.
LB.1, accounting for 17.5% of infections, is quickly becoming the most prevalent variant. Early studies suggest that LB.1 might be more infectious and better at evading immunity from vaccines or previous infections compared to the FLiRT variants.

What we know about symptoms

Despite the new variants, Covid-19 symptoms have remained relatively consistent over the past few years. Common symptoms include a high temperature or shivering, a new continuous cough, loss or change in taste or smell, shortness of breath, fatigue, body aches, headache, sore throat, runny nose, loss of appetite, diarrhea, and nausea or vomiting.

How serious is the situation?

The overall picture shows a moderate increase in Covid-19 cases and hospitalizations, but experts like Professor Paul Hunter from the University of East Anglia suggest that the current situation is not as alarming as it might seem. He notes that while there has been a slight increase in Covid-19 admissions, the rates are significantly lower than at the pandemic's peak.
Covid (1)

Covid-19 is now becoming a regular part of life, with many experts suggesting that it will eventually become another cause of the common cold. According to Professor Hunter, “We are all going to get repeated Covid infections from birth to death. Generally, the severity of illness has decreased over the past few years.”

Staying safe this summer

For those most vulnerable to Covid-19, such as older adults and immunocompromised individuals, it's recommended to stay updated with the latest vaccines and consider taking additional precautions like wearing masks in crowded spaces and avoiding large gatherings. Dr. Russo suggests that immunocompromised individuals might benefit from a monoclonal antibody drug called Pemgarda and the antiviral medication Paxlovid to reduce the risk of severe illness.

Most healthy individuals can wait for the updated Covid-19 vaccines expected in the fall, which will target the KP.2 variant. Despite ongoing evolution, these vaccines should offer good protection against the circulating variants.
author
About the Author
TOI Lifestyle Desk

The TOI Lifestyle Desk is a dynamic team of dedicated journalists who, with unwavering passion and commitment, sift through the pulse of the nation to curate a vibrant tapestry of lifestyle news for The Times of India readers. At the TOI Lifestyle Desk, we go beyond the obvious, delving into the extraordinary. Consider us your lifestyle companion, providing a daily dose of inspiration and information. Whether you're seeking the latest fashion trends, travel escapades, culinary delights, or wellness tips, the TOI Lifestyle Desk is your one-stop destination for an enriching lifestyle experience.

End of Article
FOLLOW US ON SOCIAL MEDIA